Artelo Biosciences, ART26.12, BIO-Europe 2026, FABP5, FABP5 Inhibitor, Fatty Acid Binding Protein 5, Pain, Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy,

SOLANA BEACH, Calif. — October 7, 2026 Artelo Biosciences announced that it has been selected to deliver its first-ever...